Skip to main content

Journals in Neurophysiology

Autonomic Neuroscience: Basic and Clinical

  • ISSN: 1566-0702
  • 5 Year impact factor: 2.9
  • Impact factor: 3.2
Official publication of The International Society for Autonomic NeuroscienceThis is an international journal with broad coverage of all aspects of the autonomic nervous system in man and animals. The main areas of interest include the innervation of blood vessels and viscera, autonomic ganglia, efferent and afferent autonomic pathways, and autonomic nuclei and pathways in the central nervous system.The Editors will consider papers that deal with any aspect of the autonomic nervous system, including structure, physiology, pharmacology, biochemistry, development, evolution, ageing, behavioural aspects, integrative role and influence on emotional and physical states of the body. Interdisciplinary studies will be encouraged. Studies dealing with human pathology will be also welcome.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.

Brain Multiphysics

  • ISSN: 2666-5220
A multidisciplinary journal dedicated to the physics of the brain and its biological and clinical implications in:Brain development (e.g., morphogenesis, neural networks),Brain physiology and function (e.g., regulation, neuromodulation),Brain pathology (e.g., neurodegeneration, TBI, cancer, stroke).The journal offers an open-access multidisciplinary publishing platform (under the format of letters, research articles, and reviews) to researchers interested in physical aspects of the brain. The journal will consider experimental, clinical, theoretical, and computational studies aimed at improving our understanding of the brain or developing new methods to probe the fascinating inner working of the brain. Authors are welcome to contact the Editors-in-Chief ahead of submission to ask whether their work is suitable for the journal.

Clinical Neurophysiology

  • ISSN: 1388-2457
  • 5 Year impact factor: 3.9
  • Impact factor: 3.7
Official Organ of the International Federation of Clinical Neurophysiology, the Brazilian Society of Clinical Neurophysiology, the Czech Society of Clinical Neurophysiology, and the International Society of Intraoperative Neurophysiology.SCOPE OF THE JOURNAL: Clinical Neurophysiology is dedicated to publishing scholarly reports on the pathophysiology underlying diseases of the peripheral and central nervous system of humans. Reports on clinical trials that use neurophysiological measures as endpoints are encouraged, as are manuscripts on integrated neuroimaging of peripheral and central nervous function including, but not limited to, functional MRI, brain mapping, MEG, EEG, PET, ultrasound, and other neuroimaging modalities. Studies on normal human neurophysiology are welcome, if they are relevant to disease or clinical applications. Studies on animals and technical reports must have clear applicability to human disease. Case reports may be considered (exclusively as Letters-to-the-Editor), if implying substantial advancement of knowledge.Clinical Neurophysiology covers epilepsy, developmental clinical neurophysiology, psychophysiology and psychopathology, motor control and movement disorders, somatosensory disorders including pain, motor neuron diseases, neuromuscular diseases, neuropathies, sleep and disorders of consciousness, auditory and vestibular disorders, aging, Alzheimer's disease, other dementias, other psychiatric disorders, autonomic disorders, neural plasticity and recovery, intraoperative and ICU monitoring, and therapeutic clinical neurophysiology including non-invasive and invasive brain stimulation.All studies published in Clinical Neurophysiology must stand on their own and make a substantial contribution to the literature. The journal does not afford a high priority to 'pilot' or 'preliminary' studies or to negative studies that do not advance knowledge.Reports with a focus on education or clinical practice, case reports, methodological and technical reports and studies reporting normative data on healthy subjects are preferentially being considered in Clinical Neurophysiology Practice, a companion journal of Clinical Neurophysiology.AUDIENCE:Neurologists, Clinical Neurophysiologists, Neuroscientists, Neuroimagers, Psychiatrists, Neuropsychologists, NeurosurgeonsSee also the BRAND NEW Companion Journal Clinical Neurophysiology Practice

Clinical Neurophysiology Practice

  • ISSN: 2467-981X
  • 5 Year impact factor: 2.3
  • Impact factor: 2
Official Organ of the International Federation of Clinical Neurophysiology. Clinical Neurophysiology Practice is a companion journal to Clinical NeurophysiologyClinical Neurophysiology Practice (CNP) is a new Open Access journal that focuses on clinical practice issues in clinical neurophysiology including relevant new research, case reports or clinical series, normal values and didactic reviews. It is an official journal of the International Federation of Clinical Neurophysiology and complements Clinical Neurophysiology which focuses on innovative research in the specialty. It has a role in supporting established clinical practice, and an educational role for trainees, technicians and practitioners.Types of manuscripts for consideration include: educational reviews and expert-consensus clinical practice guidelines, original research papers (including papers reporting normative data), extended case reports, systematic reviews, editorials, and Letters to the Editor.As a journal devoted to education and evidence-based clinical practice in the specialty, the priorities for Clinical Neurophysiology Practice differ from those of our companion IFCN journal Clinical Neurophysiology. Novelty is a critical issue for research-focused journals such as Clinical Neurophysiology, but is less important for Clinical Neurophysiology Practice. Quality papers may be rejected by research-focused journals because the studies do not report new advances in knowledge or are of low (research) impact, or because studies are deemed incremental, confirmatory, negative or outside journal priorities. However in clinical practice negative studies may be just as important as positive studies, and well-conceived papers reporting negative data or confirmatory results are welcome because clinical advances need confirmation before they are introduced into clinical care. Similarly, case reports can be particularly educational and are welcome. Case reports must have a neurophysiological focus and illustrate the diagnostic process, using figures that are of high quality. These reports are not specifically limited in length, the number of figures or the number of references.

Hearing Research

  • ISSN: 0378-5955
  • 5 Year impact factor: 2.9
  • Impact factor: 2.5
The aim of the journal is to provide a forum for papers concerned with basic peripheral and central auditory mechanisms. Emphasis is on experimental and clinical studies, but theoretical and methodological papers will also be considered. The journal publishes original research papers, review and mini- review articles, rapid communications, method/protocol and perspective articles.Papers submitted should deal with auditory anatomy, physiology, psychophysics, imaging, modeling and behavioural studies in animals and humans, as well as hearing aids and cochlear implants. Papers dealing with the vestibular system are also considered for publication. Papers on comparative aspects of hearing and on effects of drugs and environmental contaminants on hearing function will also be considered. Clinical papers will be accepted when they contribute to the understanding of normal and pathological hearing functions.AUDIENCEAudiologists, Biologists, Otologists, Physiologists, Neurologists, Neuroscientists, Psychologists.

Heliyon

  • ISSN: 2405-8440
  • 5 Year impact factor: 3.9
  • Impact factor: 3.4
Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Journal of Physiology - Paris

  • ISSN: 0928-4257
Each issue of the Journal of Physiology (Paris) is specially commissioned, and provides an overview of one important area of neuroscience, delivering review and research papers from leading researchers in that field. The content will interest both those specializing in the experimental study of the brain and those working in interdisciplinary fields linking theory and biological data, including cellular neuroscience, mathematical analysis of brain function, computational neuroscience, biophysics of brain imaging and cognitive psychology.This is also a forum where the proceedings of specialized symposia can be published as a collection of full-length articles and the https://www.journals.elsevier.com/journal-of-physiology-paris/editorial-board/Editor-in Chief welcomes suggestions.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our https://www.elsevier.com/authors/author-servicesauthor services.Please see our https://www.elsevier.com/journals/journal-of-physiology-paris/0928-4257/guide-for-authorsGuide for Authors for information on article submission. If you require any further information or help, please visit our https://service.elsevier.com/app/home/supporthub/publishing/Support Center

Neuromuscular Disorders

  • ISSN: 0960-8966
  • 5 Year impact factor: 3.2
  • Impact factor: 2.7
Neuromuscular Disorders is the official Journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.The journal is a platform for clinical academics and scientists to publish their research results from studies on neuromuscular diseases including acquired and hereditary diseases that affect the muscle, the neuromuscular junction or the lower motor neuron.The research articles may include clinical aspects, such as new clinical entities, progress in diagnostics, treatment and management or research on cell or animal models of relevance to the clinical conditions.Review articles by renowned clinical academics or scientists on the topics mentioned above are welcome. Review articles by uncredited contributors will not be accepted.Reports from international workshops may be considered especially when they include consensus on guidelines regarding diagnostics, nomenclature, treatment outcome measures or other research strategies of general international interest.Case reports will only be considered if they provide an in-depth analysis of specific neuromuscular disorders that could serve as exemplary models for future research in the field. Reports on new mutations in already known genes or combinations of pathologies in the same individual will not be accepted unless they offer new insights of broader significance.Socio-economic studies and survey reports based on non-validated questionnaires will usually not be considered.

Neuropharmacology

  • ISSN: 0028-3908
  • 5 Year impact factor: 4.5
  • Impact factor: 4.6
Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.Neuropharmacology also publishes topical narrative reviews on subjects within its remit. These reviews are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief of their intention to submit a review. Potential review authors should clearly indicate in the cover letter their expertise in the area, the timeliness of the topic, and how the review differs from, and adds to, recent published reviews on related topics. Authors are expected to have an established experimental track record in the topic of the review, and should provide full citations, including URLs/DOIs, of recent experimental papers in peer-reviewed journals relevant to the topic of the review in their cover letter. In the absence of an experimental track record, authors should provide a justification for why they believe they are the right persons to author this review article at this point in time. The absence of any such evidence of relevant experimental expertise or an explanation of author appropriateness will result in the return of the manuscript to the authors. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a prompt decision regarding the proposed review. Systematic reviews, meta- or bibliographic analyses will not be considered unless they are a necessary part of a Special Issue and conducted by experts in the field, and even then only under exceptional circumstances and at the discretion of the Editor-in-Chief.

Parkinsonism & Related Disorders

  • ISSN: 1353-8020
  • 5 Year impact factor: 3.8
  • Impact factor: 3.1
Official Journal of the International Association of Parkinsonism and Related Disorders Parkinsonism & Related Disorders is a companion journal to Clinical Parkinsonism & Related DisordersParkinsonism & Related Disorders publishes the results of translational and clinical research contributing to the understanding, diagnosis and treatment of movement disorders and all neurodegenerative syndromes in which parkinsonism, essential tremor or related movement disorders may be a feature. Parkinsonism & Related Disorders welcomes reviews, points of views, original articles, short communications, interesting cases for movement disorder rounds and correspondences to the editor.Topics covered will include: • Molecular biology • Neuroanatomy • Neurophysiology/electrophysiology • Neuropharmacology • Neuropsychology • Neuroimaging • Neurotoxicology • Clinical phenomenology • Surgical and pharmacological treatment • Transplantation studies • Relationship with aging • Epidemiology/environmental impact factors • RehabilitationThe journal will form a truly international channel of communication between the research and clinical communities.Manuscripts with a primary focus on clinical aspects of movement disorders should be submitted to Clinical Parkinsonism & Related Disorders .